Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (391-400 of 676) with videos related to

Pageof 68
Sort By:
Oncotarget|April 28, 2016
Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibitionAsneha Iqbal, Frank Eckerdt, Jonathan Bell, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|May 22, 2014
Identification of a transcriptional signature for the wound healing continuumMatthew A Peake, Mathew Caley, Peter J Giles, et al.
Leukemia & Lymphoma|August 3, 2002
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disordersApostolia M Tsimberidou, Susan M O'Brien, Jorge E Cortes, et al.
Inorganic Chemistry|April 30, 2014
Ligand control of donor-acceptor excited-state lifetimesJing Yang, Dominic K Kersi, Logan J Giles, et al.
Oncotarget|December 8, 2016
Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsRicardo Costa, Cesar A Santa-Maria, Giovanna Rossi, et al.
Oncogene|October 18, 2011
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myelomaK R Kelly, C M Espitia, D Mahalingam, et al.
Seminars in Oncology|May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemiaFrancis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
Annals of Internal Medicine|October 1, 1996
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemiaM W Kattan, Y Inoue, F J Giles, et al.
Blood|May 16, 2002
Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemiaElihu H Estey, Francis J Giles, Miloslav Beran, et al.
Leukemia Research|July 16, 2003
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemiaApostolia Tsimberidou, Jorge Cortes, Deborah Thomas, et al.
Pageof 68

Showing results (391-400 of 676) with videos related to

Sort By:
Pageof 68
Oncotarget|April 28, 2016
Targeting of glioblastoma cell lines and glioma stem cells by combined PIM kinase and PI3K-p110α inhibitionAsneha Iqbal, Frank Eckerdt, Jonathan Bell, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|May 22, 2014
Identification of a transcriptional signature for the wound healing continuumMatthew A Peake, Mathew Caley, Peter J Giles, et al.
Leukemia & Lymphoma|August 3, 2002
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disordersApostolia M Tsimberidou, Susan M O'Brien, Jorge E Cortes, et al.
Inorganic Chemistry|April 30, 2014
Ligand control of donor-acceptor excited-state lifetimesJing Yang, Dominic K Kersi, Logan J Giles, et al.
Oncotarget|December 8, 2016
Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsRicardo Costa, Cesar A Santa-Maria, Giovanna Rossi, et al.
Oncogene|October 18, 2011
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myelomaK R Kelly, C M Espitia, D Mahalingam, et al.
Seminars in Oncology|May 3, 2008
Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemiaFrancis J Giles, Daniel J DeAngelo, Michele Baccarani, et al.
Annals of Internal Medicine|October 1, 1996
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemiaM W Kattan, Y Inoue, F J Giles, et al.
Blood|May 16, 2002
Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemiaElihu H Estey, Francis J Giles, Miloslav Beran, et al.
Leukemia Research|July 16, 2003
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemiaApostolia Tsimberidou, Jorge Cortes, Deborah Thomas, et al.
Pageof 68